{
    "nct_id": "NCT04134260",
    "official_title": "Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging Into Salvage Treatment for Patients With Node-Positive Prostate Cancer After Radical Prostatectomy (INNOVATE*) *INtensifying Treatment for NOde Positive Prostate Cancer by VArying the Hormonal ThErapy",
    "brief_title": "Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial",
    "cancer_type_display": "A study for patients with node-positive prostate cancer who have undergone a radical prostatectomy.",
    "cancer_tags": [
      "Prostate Adenocarcinoma",
      "Stage I Prostate Cancer AJCC v8",
      "Stage II Prostate Cancer AJCC v8",
      "Stage III Prostate Cancer AJCC v8",
      "Stage IVA Prostate Cancer AJCC v8"
    ],
    "link_to_trial": "https://clinicaltrials.gov/study/NCT04134260",
    "phase": "Phase 3",
    "recruitment_status": "RECRUITING",
    "last_update_date": "2025-09-08",
    "enrollment": 586,
    "min_age": 18,
    "max_age": null,
    "sex": "MALE",
    "is_metastatic_allowed": false,
    "performance_status_scale": "ECOG",
    "performance_status_values": [
      0,
      1
    ],
    "min_prior_lines": null,
    "max_prior_lines": null,
    "prior_treatments_required": [
      "Radical prostatectomy"
    ],
    "prior_treatments_excluded": [
      "Prior systemic chemotherapy for the study cancer",
      "Prior radiotherapy to the region of the study cancer",
      "Androgen deprivation therapy (ADT) prior to radical prostatectomy",
      "Prior treatment with androgen receptor signaling inhibitor (abiraterone acetate, enzalutamide, apalutamide, darolutamide)"
    ],
    "principal_investigator": "Ronald C Chen",
    "site_name": null,
    "contact_email": null,
    "contact_phone": "715-422-7718",
    "locations": [{"facility":"Grady Health System","status":"RECRUITING","city":"Atlanta","state":"Georgia","zip":"30303","country":"United States","contacts":[{"name":"Site Public Contact","role":"CONTACT","phone":"404-778-1868"},{"name":"Ashesh B. Jani","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"Emory Proton Therapy Center","status":"RECRUITING","city":"Atlanta","state":"Georgia","zip":"30308","country":"United States","contacts":[{"name":"Site Public Contact","role":"CONTACT","phone":"404-251-2854","email":"allyson.anderson@emory.edu"},{"name":"Ashesh B. Jani","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"Emory University Hospital Midtown","status":"RECRUITING","city":"Atlanta","state":"Georgia","zip":"30308","country":"United States","contacts":[{"name":"Site Public Contact","role":"CONTACT","phone":"888-946-7447"},{"name":"Ashesh B. Jani","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"Emory University Hospital/Winship Cancer Institute","status":"RECRUITING","city":"Atlanta","state":"Georgia","zip":"30322","country":"United States","contacts":[{"name":"Site Public Contact","role":"CONTACT","phone":"404-778-1868"},{"name":"Ashesh B. Jani","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"Emory Saint Joseph's Hospital","status":"RECRUITING","city":"Atlanta","state":"Georgia","zip":"30342","country":"United States","contacts":[{"name":"Site Public Contact","role":"CONTACT","phone":"404-851-7115"},{"name":"Ashesh B. Jani","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"Emory Decatur Hospital","status":"RECRUITING","city":"Decatur","state":"Georgia","zip":"30033","country":"United States","contacts":[{"name":"Site Public Contact","role":"CONTACT","phone":"440-778-1868","email":"clinicaltrialsoncology@dekalbmedical.org"},{"name":"Ashesh B. Jani","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":33.77483,"lon":-84.29631}},{"facility":"Emory Johns Creek Hospital","status":"RECRUITING","city":"Johns Creek","state":"Georgia","zip":"30097","country":"United States","contacts":[{"name":"Site Public Contact","role":"CONTACT","phone":"404-778-5714","email":"m.lisa.hwang@emory.edu"},{"name":"Ashesh B. Jani","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":34.02893,"lon":-84.19858}}],
    "key_inclusion_summary": [
      "Pathologically proven diagnosis of prostate adenocarcinoma.",
      "Must have undergone a radical prostatectomy.",
      "Pathologically confirmed node-positive disease confined to the pelvis.",
      "Must have a detectable PSA after radical prostatectomy.",
      "Eastern Cooperative Oncology Group (ECOG) performance status of 0-1."
    ],
    "key_exclusion_summary": [
      "Definitive radiologic evidence of metastatic disease (M1a, M1b or M1c).",
      "Prior systemic chemotherapy for prostate cancer.",
      "Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields.",
      "History of seizure or a known condition that may pre-dispose to seizure.",
      "Severe or unstable angina, myocardial infarction, or other significant cardiovascular events within 12 months prior to registration."
    ]
  }